Administering As-Needed Labetalol to Patients on Oral Metoprolol

Pharmacological Considerations

The European Society of Cardiology recommends that administering labetalol as needed to patients already taking oral metoprolol is not recommended due to the risk of excessive beta-blockade that could lead to bradycardia, hypotension, or cardiogenic shock 1, 2
Concurrent use of metoprolol and labetalol creates a risk of additive beta-blockade effects, potentially causing bradycardia 1, hypotension 3, heart failure exacerbation 4, and cardiogenic shock in susceptible patients 1, 5
Metoprolol is a selective beta-1 blocker 2

Patients at highest risk for complications from excessive beta-blockade include those with age >70 years 5, 4, systolic blood pressure <120 mmHg 5, 4, heart rate <60 bpm or >110 bpm 5, 4, signs of heart failure or low cardiac output 6, Killip class >1 (presence of heart failure) 5, PR interval >0.24 seconds 6, second or third-degree heart block 6, and active asthma or reactive airway disease 6

The American College of Cardiology recommends considering non-beta-blocker alternatives for acute blood pressure management, such as calcium channel blockers (e.g., nicardipine) 1, ACE inhibitors or ARBs for long-term control 3, 6, and nitrates for hypertension with ongoing chest pain 6
In specific clinical scenarios where both agents might be considered, such as acute aortic dissection, combining different beta-blockers is not recommended, and a single agent with adequate dosing should be used 1
For severe pre-eclampsia, labetalol is recommended, but should replace rather than supplement metoprolol 1

When transitioning between beta-blockers, the American Heart Association recommends gradually tapering the first beta-blocker before initiating the second to avoid excessive beta-blockade 2
During any transition period, vital signs should be monitored closely 7
In the rare circumstance where labetalol might be considered in a patient on metoprolol, continuous cardiac monitoring should be provided 7, resuscitation equipment should be immediately available 7, and preparation should be made to treat bradycardia or hypotension 7